{"id":"https://openalex.org/W2393461528","doi":null,"title":"Effects of Glimepiride and Glibenclamide on Carotid Atherosclerosis in Type 2 Diabetic Patients","display_name":"Effects of Glimepiride and Glibenclamide on Carotid Atherosclerosis in Type 2 Diabetic Patients","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2393461528","mag":"2393461528"},"language":"en","primary_location":{"id":"mag:2393461528","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYA201316024.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764872640","display_name":"Zhongguo yaofang","issn_l":"1001-0408","issn":["1001-0408"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322615966","host_organization_name":"China Pharmacy Publishing House","host_organization_lineage":["https://openalex.org/P4322615966"],"host_organization_lineage_names":["China Pharmacy Publishing House"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yaofang","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090242749","display_name":"Yang Yu-tian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103755","display_name":"Dahua Hospital","ror":"https://ror.org/017qjg066","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103755"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yang Yu-tian","raw_affiliation_strings":["Shanghai Xuhui District Dahua Hospital,Shanghai 200000,China)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Xuhui District Dahua Hospital,Shanghai 200000,China)","institution_ids":["https://openalex.org/I4210103755"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090242749"],"corresponding_institution_ids":["https://openalex.org/I4210103755"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.32733083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.02710000053048134,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":1.0},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":1.0},{"id":"https://openalex.org/keywords/carotid-atherosclerosis","display_name":"carotid atherosclerosis","score":0.9300000071525574},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9390000104904175},{"id":"https://openalex.org/keywords/carotid-intima-media-thickness","display_name":"carotid intima-media thickness","score":0.9810000061988831},{"id":"https://openalex.org/keywords/atherosclerosis-progression","display_name":"atherosclerosis progression","score":0.8569999933242798},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8690000176429749},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.9927507042884827},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.9749780297279358},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8610851764678955},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6330658197402954},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5893566012382507},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5687065720558167},{"id":"https://openalex.org/C2779339615","wikidata":"https://www.wikidata.org/wiki/Q2698596","display_name":"Intima-media thickness","level":3,"score":0.5209356546401978},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.44051769375801086},{"id":"https://openalex.org/C2987047532","wikidata":"https://www.wikidata.org/wiki/Q214275","display_name":"Carotid arteries","level":2,"score":0.3303975760936737},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.27101796865463257}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2393461528","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYA201316024.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764872640","display_name":"Zhongguo yaofang","issn_l":"1001-0408","issn":["1001-0408"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322615966","host_organization_name":"China Pharmacy Publishing House","host_organization_lineage":["https://openalex.org/P4322615966"],"host_organization_lineage_names":["China Pharmacy Publishing House"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yaofang","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064617441","https://openalex.org/W7127637057","https://openalex.org/W4403807772","https://openalex.org/W2072765033","https://openalex.org/W1997416444","https://openalex.org/W2416842703","https://openalex.org/W3159578775","https://openalex.org/W2341560996","https://openalex.org/W2388438167","https://openalex.org/W1968973887"],"abstract_inverted_index":{"OBJECTIVE:To":[0],"observe":[1],"the":[2,44,98],"effects":[3],"of":[4,38,46,50,58,74],"glimepiride":[5,25,64,80],"and":[6,27],"glibenclamide":[7,28,70,86,104],"on":[8,43],"carotid":[9,51,106],"atherosclerosis":[10,107],"in":[11,60,66,76,82,97,108],"type":[12,18,109],"2":[13,19,39,92,110],"diabetic":[14,111],"patients.METHODS:40":[15],"patients":[16,61,67,77,83],"with":[17,63,69,79,85],"diabetes":[20],"were":[21,41],"randomly":[22],"divided":[23],"into":[24],"group":[26],"group,and":[29],"a":[30],"3-year":[31],"observation":[32],"study":[33],"was":[34,88,94],"performed.The":[35],"clinical":[36],"efficacies":[37],"groups":[40],"evaluated":[42],"basis":[45],"annual":[47,56,72],"progression":[48,57,73],"level":[49],"intima-media":[52,54],"thickness(max":[53],"thickness,Max-IMT).RESULTS:The":[55],"Mean-IMT":[59],"treated":[62,68,78,84],"was(0.041\u00b10.103)and":[65],"was(0.012\u00b10.121);the":[71],"Max-IMT":[75],"was(-0.044\u00b10.171)and":[81],"was(0.077\u00b10.203);there":[87],"statistical":[89],"significance":[90],"between":[91],"groups(P=0.047).There":[93],"no":[95],"ADR":[96],"treatment.CONCLUSION:Glimepiride":[99],"is":[100],"more":[101],"effective":[102],"than":[103],"for":[105],"patients.":[112]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}